#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Transitional cell cancer of the renal pelvis and ureter PIK3CA-activated mutation Depression Progressive familial intrahepatic cholestasis Squamous cell carcinoma of the oral cavity C3 glomerulopathy Heritable pulmonary arterial hypertension Breast cancer Synovial sarcoma metastatic Anal fistula Neuroendocrine cell hyperplasia of infancy Neuroendocrine tumour Peritoneal mesothelioma malignant Meningococcal immunisation Post transplant lymphoproliferative disorder More trials…

    Learn about Rare Diseases

    Leukoencephalopathy Ewing’s sarcoma – Basic Information Congenital hypotransferrinaemia – Basic Information Hereditary ataxia – Life with Disease Primary hyperoxaluria – Diagnostics Glomerulonephritis membranous – Basic Information Lymphangioma – Trials in Disease Lysosomal storage disorder Basal cell naevus syndrome – Life with Disease Inclusion body myositis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Anhydrous Benzoyl Peroxide Felzartamab Sparsentan Human Coagulation Factor X RIKKUNSHITO Clopidogrel Ontasameran Itacitinib Ethambutol Hydrochloride Gemlapodect Evx-01 GSKVX000000070250 Elenestinib Phosphate Octreotide Estradiol Hemihydrate Diclofenac Palonosetron Rezafungin Acetate Oxybuprocaine Hydrochloride Avalglucosidase Alfa More therapies…

    Learn about Your Condition

    Infant sedation Penile squamous cell carcinoma Oesophageal food impaction Breast cancer stage IV Skin disorder Postoperative wound infection Oesophageal achalasia Prostate cancer recurrent Paresis Choroidal neovascularisation CDKL5 deficiency disorder Aneurysm ruptured Chronic kidney disease Cholangitis sclerosing Biliary tract operation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire Rouen

Centre Hospitalier Universitaire Rouen

1 Rue De Germont, Bp 96031, Rouen, 76031, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects of Bosentan on Blood Pressure in Patients with Uncontrolled Hypertension

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Hypertension
    Investigated Drugs:
    • Bosentan
    France

  • Study of remibrutinib for long-term treatment of adult patients with chronic spontaneous urticaria who completed previous remibrutinib studies

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chronic spontaneous urticaria
    Investigated Drugs:
    • Remibrutinib
    Bulgaria Czechia Denmark France Germany Hungary +4

  • Study on BI 1839100 for Reducing Cough in Patients with Idiopathic or Progressive Pulmonary Fibrosis

    Not recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    • Pulmonary fibrosis
    Investigated Drugs:
    • Bi 1839100
    Austria Belgium Czechia Denmark Finland France +9

  • Study of amlitelimab injection compared to placebo for adults with severe alopecia areata (hair loss)

    Not recruiting

    2 1
    Investigated Diseases:
    • Alopecia areata
    Investigated Drugs:
    • Amlitelimab
    Bulgaria Czechia France Germany Italy The Netherlands +2

  • Study on Remibrutinib for Adults with Chronic Inducible Urticaria Uncontrolled by H1-Antihistamines

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cold urticaria
    Investigated Drugs:
    • Remibrutinib
    France Germany Hungary Italy The Netherlands Poland +4

  • Study on the Effects of Inhaled Treprostinil for Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    3 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Treprostinil
    Belgium Denmark France Germany Italy The Netherlands +1

  • Study on the Long-Term Safety of Pimavanserin for Treating Irritability in Children and Adolescents with Autism Spectrum Disorder

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Autism spectrum disorder
    Investigated Drugs:
    • Pimavanserin Tartrate
    France Hungary Italy Poland Spain

  • Study on Anifrolumab for Adults with Chronic or Subacute Cutaneous Lupus Erythematosus Unresponsive to Antimalarial Therapy

    Not recruiting

    3 1
    Investigated Drugs:
    • Anifrolumab
    Austria Bulgaria Denmark France Germany Greece +7

  • Study on BI 1819479 to Improve Lung Function in Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Bi 1819479
    Austria Belgium Czechia Denmark Finland France +8

  • Study on the Effects of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Sonelokimab
    Belgium Bulgaria Czechia France Germany Ireland +4
Previous Page
1 … 32 33 34 35 36 … 48
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!